文献速递神经

卒中影像组学研究质量评估:RQS、MINIMAR与TRIPOD评分揭示报告与验证不足

Quality assessment of stroke radiomics studies: Promoting clinical application.
PubMed 文献 · Eur J Radiol · 2023-02-24

该研究检索PubMed和Embase,纳入52篇卒中影像组学原始研究,用RQS、MINIMAR和TRIPOD评分评估质量。结果显示仅7.7%研究进行外部验证,平均RQS仅3.2/36(8.9%),MINIMAR依从率47.4%,TRIPOD依从率54.6%。结论认为卒中影像组学研究的报告质量和验证不足,需更充分验证和开放数据以提升临床适用性。

要点

  • 仅7.7%的卒中影像组学研究进行了外部验证,临床转化证据薄弱。
  • 平均RQS仅3.2/36(8.9%),无研究进行重测信度、生物学相关性验证或前瞻性设计。
  • MINIMAR和TRIPOD依从率分别为47.4%和54.6%,标题和样本量报告依从率极低(2.0%)。

核心结论

  • 已发表的卒中影像组学研究整体报告质量欠佳,外部验证和开放数据不足,限制临床适用性。

研究设计与样本

  • 研究为文献质量评估,检索PubMed MEDLINE和Embase,从464篇文章中纳入52篇卒中影像组学原始研究。
  • 由神经放射科医生使用RQS、MINIMAR和TRIPOD三种工具对纳入研究进行评分。

诊断标准与关键数值

  • 仅4项研究(7.7%)进行了外部验证;平均RQS为3.2/36(8.9%),基本依从率为24.9%。
  • RQS中体模研究、与金标准比较、潜在临床效用和成本效益分析的依从率分别为1.9%、1.9%、13.5%和1.9%。
  • 无研究进行重测信度、声明生物学相关性、开展前瞻性研究或公开代码和数据。
  • MINIMAR总依从率为47.4%;TRIPOD总体依从率为54.6%,标题、研究设置关键要素和样本量解释的依从率分别为2.0%、6.1%和2.0%。

临床应用与阅片要点

  • 阅片或解读卒中影像组学研究时,应关注是否报告外部验证、金标准比较和临床效用,避免直接采信缺乏验证的模型。
  • 报告影像组学研究时,应按MINIMAR和TRIPOD清单完整报告标题、研究设置和样本量等关键要素。

局限性

  • 原文未明确报告局限性;研究设计为文献质量评估,仅纳入PubMed和Embase索引的英文原始研究,可能存在选择偏倚和语言偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the quality of radiomics studies on stroke using a radiomics quality score (RQS), Minimum Information for Medial AI reporting (MINIMAR) and Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) to promote clinical application.

METHODS: PubMed MEDLINE and Embase were searched to identify radiomics studies on stroke. Of 464 articles, 52 relevant original research articles were included. The RQS, MINIMAR and TRIPOD were scored to evaluate the quality of the studies by neuroradiologists.

RESULTS: Only four studies (7.7 %) performed external validation. The mean RQS was 3.2 of 36 (8.9 %), and the basic adherence rate was 24.9 %. The adherence rate was low for conducting phantom study (1.9 %), stating comparison to 'gold standard' (1.9 %), offering potential clinical utility (13.5 %) and performing cost-effectiveness analysis (1.9 %). None of the studies performed a test-retest, stated biologic correlation, conducted prospective studies, or opened codes and data to the public, resulting in low RQS. The total MINIMAR adherence rate was 47.4 %. The overall adherence rate for TRIPOD was 54.6 %, with low scores for reporting the title (2.0 %), key elements of the study setting (6.1 %), and explaining the sample size (2.0 %).

CONCLUSIONS: The overall radiomics reporting quality and reporting of published radiomics studies on stoke was suboptimal. More thorough validation and open data are needed to increase clinical applicability of radiomics studies.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Sohn, Won. Quality assessment of stroke radiomics studies: Promoting clinical application. Eur J Radiol. 2023. PMID: 36878154. doi:10.1016/j.ejrad.2023.110752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。